SARCOMAS

Clinical trials for SARCOMAS explained in plain language.

Never miss a new study

Get alerted when new SARCOMAS trials appear

Sign up with your email to follow new studies for SARCOMAS, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Not yet recruiting 1 Not yet finished but already full! 1

New pill targets cancer's genetic weak spot in 15 tumor types

Disease control Ongoing

This study tests a drug called entrectinib in people with advanced solid tumors that have certain gene changes (NTRK, ROS1, or ALK). The drug aims to shrink or control the cancer by blocking these faulty genes. About 534 adults with various cancers, including lung, breast, and br…

Matched conditions: SARCOMAS

Phase: PHASE2 • Sponsor: Hoffmann-La Roche • Aim: Disease control

Last updated Apr 29, 2026 02:38 UTC

SARCOMAS

Get alerted when new SARCOMAS trials appear

New pill targets cancer's genetic weak spot in 15 tumor types